RLX Technology Inc is engaged in the manufacturing of e-vapor products for adult smokers... Show more
In recent trading sessions, RLX Technology (RLX) stock has hovered around the $2.10 level, within its 52-week range of approximately $1.87 to $2.84. The shares have experienced modest volatility amid broader market cycles, with a year-to-date decline but positive one-year returns driven by strong fiscal performance. Trading volume has been below average in recent weeks, signaling investor caution ahead of upcoming quarterly results. The stock's price-to-earnings ratio stands in the low 20s, reflecting improved profitability from margin expansion and revenue growth. Overall, RLX maintains a stable presence in the consumer staples sector, supported by its dominant position in branded e-vapor products.
Tickeron's Trending AI Robots page showcases the top 25 AI trading bots selected from a total of 351 available on the platform, curated for their superior performance in current market conditions. These bots trade thousands of tickers across stocks, ETFs, and crypto, employing diverse strategies such as trend analysis, multi-agent systems, and take-profit/stop-loss corridors on timeframes ranging from 5 minutes to 60 minutes. Performance stats are compelling, with annualized returns reaching up to +285% (e.g., in space infrastructure), win rates between 50% and 88%, and profit factors from 1.5 to 11.7. Focused on high-growth sectors like semiconductors, AI infrastructure, and industrials, these bots offer investors automated, data-driven opportunities tailored to volatile environments. Explore the Trending AI Robots to identify those aligning with your trading style and risk tolerance.
RLX Technology, a leading global branded e-vapor company, has seen its stock price stabilize in recent weeks following key corporate milestones. The most notable development within the past 30 days was the filing of its 2025 annual report on Form 20-F with the U.S. Securities and Exchange Commission (SEC) on April 23, 2026. This routine but critical disclosure provides detailed financials, operational updates, and risk factors for the fiscal year ended December 31, 2025, underscoring the company's commitment to transparency for NYSE-listed ADRs (American Depositary Receipts).
Building on earlier momentum, RLX's fiscal 2025 results—released March 13 but influencing ongoing sentiment—highlighted exceptional growth. Net revenues surged 44% to RMB 3,958.9 million (about US$557 million), with Q4 alone up 40.3% to RMB 1,141.3 million (US$163.2 million). International sales comprised 76.5% of Q4 revenue, reflecting successful expansion into Asia-Pacific and Europe amid China's stringent domestic regulations on e-cigarettes. Gross margins expanded to 29.9% for the year (31.4% in Q4), driven by scalable operations and premium branding. Non-GAAP operating income doubled to RMB 570 million, while net income rose 67% to RMB 922 million. Cash and equivalents stood at RMB 15.7 billion (over US$2.2 billion), enabling aggressive shareholder returns: approximately US$330 million in share repurchases under an extended US$500 million program through 2027, plus US$171 million in dividends.
These fundamentals supported price resilience earlier in the period, but shares dipped modestly amid anticipation for Q1 2026 earnings, slated for May 15, 2026, with consensus expecting EPS of $0.031 and revenue around $167 million. Analyst actions included Citi trimming its price target from $2.60 to $2.50 (Neutral rating) on March 16, citing conservative margin outlooks, while others like Seeking Alpha maintained "Strong Buy" on international traction. Broader e-vapor industry catalysts, such as China's cancellation of VAT export rebates on nicotine products effective April 1, 2026, introduced margin pressures, tempering enthusiasm and contributing to subdued trading. No major partnerships, acquisitions, or macroeconomic shocks directly impacted RLX in the immediate period, though global harm-reduction trends bolstered sentiment. Overall, price action linked closely to fiscal strength offset by regulatory vigilance and earnings wait-and-see dynamics.
As RLX Technology advances through 2026, investors should track its multidimensional growth strategy emphasizing international markets, where sales already dominate revenue. Analysts forecast revenue expansion at 23% annually over the next three years, outpacing the global tobacco industry's 2.7% growth, fueled by distributor networks and retail penetration aiming for overseas contributions exceeding 75%. Earnings per share growth is projected at 13-14% per year, supported by operational leverage and AI-enhanced supply chains.
Key opportunities include regulatory compliance advantages in China, where crackdowns on illicit products favor licensed players like RLX, and global demand for reduced-risk alternatives. Strategic partnerships and product innovation in compliant devices could drive volume. Risks encompass tightened e-cigarette oversight, including the April 2026 VAT rebate elimination raising export costs, potential margin compression, and geopolitical tensions affecting China-based operations. Competitive pressures in fragmented international markets and supply chain disruptions warrant attention. Cost controls, cash deployment via buybacks/dividends, and Q1 results will shape trajectory. Balanced monitoring of these themes remains essential amid evolving industry dynamics.
The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full Disclaimers and Limitations.
Moving lower for three straight days is viewed as a bearish sign. Keep an eye on this stock for future declines. Considering data from situations where RLX declined for three days, in of 257 cases, the price declined further within the following month. The odds of a continued downward trend are .
The Momentum Indicator moved below the 0 level on June 12, 2026. You may want to consider selling the stock, shorting the stock, or exploring put options on RLX as a result. In of 92 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are .
The Moving Average Convergence Divergence Histogram (MACD) for RLX turned negative on June 17, 2026. This could be a sign that the stock is set to turn lower in the coming weeks. Traders may want to sell the stock or buy put options. Tickeron's A.I.dvisor looked at 53 similar instances when the indicator turned negative. In of the 53 cases the stock turned lower in the days that followed. This puts the odds of success at .
The Aroon Indicator for RLX entered a downward trend on June 22, 2026. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.
The RSI Oscillator points to a transition from a downward trend to an upward trend -- in cases where RLX's RSI Indicator exited the oversold zone, of 30 resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are .
The Stochastic Oscillator demonstrated that the ticker has stayed in the oversold zone for 2 days, which means it's wise to expect a price bounce in the near future.
Following a 3-day Advance, the price is estimated to grow further. Considering data from situations where RLX advanced for three days, in of 212 cases, the price rose further within the following month. The odds of a continued upward trend are .
RLX may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.
The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is seriously undervalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (0.980) is normal, around the industry mean (19.433). P/E Ratio (17.109) is within average values for comparable stocks, (19.647). RLX's Projected Growth (PEG Ratio) (0.000) is slightly lower than the industry average of (1.917). Dividend Yield (0.053) settles around the average of (0.045) among similar stocks. P/S Ratio (3.561) is also within normal values, averaging (2.940).
The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating slightly worse than average price growth. RLX’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating that the returns do not compensate for the risks. RLX’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 66, placing this stock worse than average.
The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows
Industry Tobacco